Healthcare provider profile · identity verified

Steven L Sobel, M.D.

Family Practice · AUBURN, CA · NPI 1891787073

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	618	187
Levothyroxine Sodium	Levothyroxine Sodium	607	174
Lisinopril	Lisinopril	533	159
Amlodipine Besylate	Amlodipine Besylate	433	129
Losartan Potassium	Losartan Potassium	372	114
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	371	72
Hydrochlorothiazide	Hydrochlorothiazide	282	86
Trazodone Hcl	Trazodone Hcl	267	60
Gabapentin	Gabapentin	258	57
Albuterol Sulfate Hfa	Albuterol Sulfate	239	79
Tamsulosin Hcl	Tamsulosin Hcl	227	72
Omeprazole	Omeprazole	212	62
Potassium Chloride	Potassium Chloride	200	59
Metoprolol Succinate	Metoprolol Succinate	193	54
Simvastatin	Simvastatin	185	47
Rosuvastatin Calcium	Rosuvastatin Calcium	173	57
Pantoprazole Sodium	Pantoprazole Sodium	162	47
Metformin Hcl	Metformin Hcl	159	49
Zolpidem Tartrate	Zolpidem Tartrate	145	29
Alprazolam	Alprazolam	131	28
Tramadol Hcl	Tramadol Hcl	117	24
Furosemide	Furosemide	116	40
Eliquis	Apixaban	106	29
Fluticasone Propionate	Fluticasone Propionate	104	36
Sertraline Hcl	Sertraline Hcl	101	31
Escitalopram Oxalate	Escitalopram Oxalate	100	27
Allopurinol	Allopurinol	99	30
Lorazepam	Lorazepam	98	37
Pravastatin Sodium	Pravastatin Sodium	98	26
Quetiapine Fumarate	Quetiapine Fumarate	97	18
Citalopram Hbr	Citalopram Hydrobromide	96	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	96	26
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	96	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	95	19
Finasteride	Finasteride	89	22
Bupropion Xl	Bupropion Hcl	88	21
Atenolol	Atenolol	85	26
Montelukast Sodium	Montelukast Sodium	85	23
Famotidine	Famotidine	83	28
Fluoxetine Hcl	Fluoxetine Hcl	82	23
Diclofenac Sodium	Diclofenac Sodium	79	24
Metoprolol Tartrate	Metoprolol Tartrate	75	25
Carvedilol	Carvedilol	74	20
Lovastatin	Lovastatin	73	23
Spironolactone	Spironolactone	71	19
Morphine Sulfate Er	Morphine Sulfate	68	suppressed
Baclofen	Baclofen	65	12
Duloxetine Hcl	Duloxetine Hcl	64	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	64	12
Metformin Hcl Er	Metformin Hcl	62	20
Aripiprazole	Aripiprazole	59	13
Estradiol	Estradiol	59	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	18
Donepezil Hcl	Donepezil Hcl	55	13
Clopidogrel	Clopidogrel Bisulfate	54	18
Glipizide Er	Glipizide	50	15
Triamcinolone Acetonide	Triamcinolone Acetonide	48	26
Venlafaxine Hcl Er	Venlafaxine Hcl	48	13
Ezetimibe	Ezetimibe	47	14
Naproxen	Naproxen	45	17
Pioglitazone Hcl	Pioglitazone Hcl	45	15
Raloxifene Hcl	Raloxifene Hcl	44	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	13
Paroxetine Hcl	Paroxetine Hcl	41	suppressed
Synthroid	Levothyroxine Sodium	40	11
Diazepam	Diazepam	39	suppressed
Ondansetron Odt	Ondansetron	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	13
Methadone Hcl	Methadone Hcl	38	suppressed
Trulicity	Dulaglutide	38	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	37	suppressed
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Terazosin Hcl	Terazosin Hcl	35	suppressed
Memantine Hcl	Memantine Hcl	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	11
Jardiance	Empagliflozin	33	suppressed
Propranolol Hcl	Propranolol Hcl	33	suppressed
Meloxicam	Meloxicam	31	suppressed
Entresto	Sacubitril/Valsartan	30	suppressed
Glipizide	Glipizide	29	suppressed
Ventolin Hfa	Albuterol Sulfate	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Fentanyl	Fentanyl	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Bumetanide	Bumetanide	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Lidocaine	Lidocaine	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Humalog	Insulin Lispro	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Acyclovir	Acyclovir	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	19
Levetiracetam	Levetiracetam	24	suppressed
Movantik	Naloxegol Oxalate	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Arnuity Ellipta	Fluticasone Furoate	22	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Prednisone	Prednisone	22	suppressed
Primidone	Primidone	22	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Bupropion Hcl	Bupropion Hcl	20	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Premarin	Estrogens, Conjugated	20	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Temazepam	Temazepam	19	suppressed
Cephalexin	Cephalexin	18	suppressed
Ciclopirox	Ciclopirox	18	suppressed
Comfort Ez Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Linzess	Linaclotide	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Telmisartan	Telmisartan	17	suppressed
Tresiba Flextouch U-200	Insulin Degludec	17	suppressed
Breyna	Budesonide/Formoterol Fumarate	16	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	16	suppressed
Eszopiclone	Eszopiclone	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Amoxicillin	Amoxicillin	15	11
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Valsartan	Valsartan	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Nystatin	Nystatin	14	suppressed
Ozempic	Semaglutide	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Fluocinonide	Fluocinonide	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Azathioprine	Azathioprine	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Naloxone Hcl	Naloxone Hcl	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Cyclosporine Modified	Cyclosporine, Modified	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Ibu	Ibuprofen	11	suppressed
Klor-Con 10	Potassium Chloride	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error